La microbiologie est la science qui s'attache à l'étude des microorganismes et de leurs propriétés. Depuis ses débuts au XV II siècle, les méthodes développées par les microbiologistes ont permis de révéler un énorme potentiel de connaissances et d'applications. Dans les dernières décennies, les industriels ont vu un intérêt tout particulier dans ce domaine d'étude. Le besoin de prévenir les contaminations en inhibant le développement microbien, ou au contraire la volonté de l'optimiser pour profiter des capacités de transformations chimiques des microorganismes a fait naître une demande croissante de tests microbiologiques. Le faible rendement des méthodes traditionnelles ne permettant pas de satisfaire à cette demande, la recherche de nouvelles méthodes de test focalise les intérêts. Les outils fluidiques miniaturisés ont d'ores et déjà fait preuve de leur potentiel pour ce type d'application, bien que leur validation vis-à-vis des méthodes classiques manque souvent.Dans ce travail de thèse, nous avons développé des incubateurs miniaturisés et des méthodes de suivi de populations de microorganismes optimisés. L'objectif est d'aborder l'impact de la réduction d'échelle d'incubation sur la croissance par rapport aux dispositifs de culture traditionnel, pour ensuite aboutir à un outil haut-débit pour la caractérisation de biocides. / Microbiology is the part of science linked with the study of microorganisms and their properties. Since its beginnings in the XV IIth century, the methods developped by the microbiologists revealed a huge potential of knowledge and applications.In the last decades, industrials realized the interests of this study areaThe need to prevent contaminations by inhibiting microbial development, or on the contrary the will to improve it to enjoy the chemical transformations capacities of the microorganisms gave birth to an increasing demand for microbiological tests. The poor yield of traditionnal methods does not allow to satisfy this need, and the search for new test methods is thus focalizing interests. Miniaturized fluidic tools have already proven their potential for this kind of applications, and yet, their validation towards traditionnal methods often lacks.In this work, we aim at developping miniaturized cultivation techniques and optimized growth analysis methods, to study the scale reduction impact of incubator's size on growth, in order to end up with a high-throughput tool for biocide caracterization.

Die Deregulation des Transkriptionsfaktors Myc ist ein charakteristisches Merkmal für eine Vielzahl von humanen Tumoren. Durch die transkriptionelle Aktivierung von Genen, die im Zusammenhang mit Metabolismus, Translation und Proliferation stehen, wird dadurch das Tumorwachstum begünstigt. Myc bildet zudem mit dem Zinkfinger-Protein Miz1 einen Komplex, der hemmend auf die Transkription von Zielgenen wirkt. Bisher sind nur wenige Myc/Miz1-reprimierte Zielgene bekannt. In der vorliegenden Arbeit konnten genomweit die DNA-Bindestellen von Myc und Miz1 durch Chromatin-Immunpräzipitationen gefolgt von Hochdurchsatzsequenzierung in einer Zervixkarzinomzelllinie bestimmt werden. Es konnte gezeigt werden, dass Myc an Promotoren aller drei RNA-Polymerasen sowie in enhancer-Regionen bindet, während Miz1 Kernpromotoren von RNA-Polymerase II- und III-transkribierten Genen besetzt. reChIP-Experimente zeigten, dass Myc und Miz1 als Komplex an Promotoren von Zielgenen binden. Zudem wurde ein Miz1-DNA-Bindemotiv identifiziert und der transaktivierende Einfluss von Miz1 auf Gene mit diesem Motiv nachgewiesen. Das überwiegende Vorhandensein von Myc/Max-Komplexen führt zu einer Transaktivierung von E-Box-haltigen Promotoren. Andererseits erfolgt die transkriptionelle Repression von Myc/Miz1-Zielgenen an Promotoren, an denen der Myc/Miz1-Komplex vorherrscht. In aktuellen Publikationen konnte gezeigt werden, dass nach mitogener Stimulation von Lymphozyten es zu einer Erhöhung der Myc-Expression kommt, wodurch Myc als ein genereller Transkriptionsaktivator fungiert, der alle Gene gleichermaßen induziert. Trotz hoher Myc-Mengen in Tumorzellen konnte die generelle Myc-vermittelte Transaktivierung nicht nachgewiesen werden. Zusätzlich zur Myc-abhängigen Transaktivierung von E-Box-haltigen Genen, z. B. beteiligt an Translation und RNA-Prozessierung, und der Miz1-vermittelten transkriptionellen Aktivierung von Genen mit Miz1-Motiv (z. B. involviert in Autophagie), konnte entgegen dem Modell der generellen Genamplifikation durch Myc eine Myc/Miz1-abhängige Repression von Zielgenen belegt werden. Die neu gewonnenen Erkenntnisse des Bindeverhaltens des Myc/Miz1-Komplexes und der daraus resultierenden transkriptionellen Regulation von Myc/Miz1-Zielgenen ermöglichen ein besseres Verständnis der Myc-Funktion in Tumorzellen und könnte zur Verbesserung von Tumortherapien führen. / Deregulation of the transcription factor Myc is a characteristic feature of a variety of human tumors. The Myc-dependent transcriptional activation of genes involved in metabolism, translation and proliferation therefor promotes tumor growth. Additionally, Myc forms a complex with the zinc finger protein Miz1, which represses transcription of target genes. So far, only a limited number of Myc/Miz1-repressed genes is known. Within the present thesis DNA binding sites of Myc and Miz1 were mapped genome-wide using chromatin immunoprecipitations followed by high-throughput sequencing in a cervical cancer cell line. It could be shown that Myc binds to promoters of all three RNA polymerases as well as to enhancer regions, whereas Miz1 binding sites could be found only in core promoters of RNA polymerase II and III transcribed genes. reChIP experiments illustrated binding of Myc and Miz1 as a complex on DNA. Additionally, a DNA binding motif of Miz1 was identified and furthermore it was possible to verify the transctivating influence of Miz1 on genes carrying that motif in the promoter. On E-box containing promoters the predominantly existence of Myc/Max complexes resulted in transactivation of the respective genes. Otherwise, transcriptional repression of Myc/Miz1 target genes occured at promoters where the Myc/Miz1 complex dominates. Recent publications have illustrated that after mitogenic stimulation of primary lymphocytes, Myc expression is enhanced, whereby Myc serves as a general transcriptional activator that induces the expression of virtually all genes. Although Myc levels are high in tumor cells that general mechanism of Myc-mediated transactivation could not be verified. Additionally to the Myc-dependent transactivation of E-box-containing genes, e. g. involved in translation and RNA processing, and Miz1-mediated transcriptional activation of genes containing a Miz1 binding motif (e. g. autophagy-related genes), and in opposition to the general amplifier model a Myc/Miz1-dependent repression of target genes could be proven. The obtained evidences concerning DNA binding properties of the Myc/Miz1 complex as well as the resulting transcriptional regulation of Myc/Miz1 target genes facilitates a better understanding of Myc function in tumor cells and could leed to better anti-tumor therapies.

Cette thèse a pour objectif de développer une méthode électrochimique permettant de cribler à haut débit des inhibiteurs d'enzymes. Pour cela, une enzyme cible a été sélectionnée pour son intérêt thérapeutique, la transcétolase (TK) : elle est impliquée dans de nombreuses pathologies (cancer, maladies neurodégénératives, diabète…) et dans la survie de certains parasites pathogènes. Afin de mesurer l'activité de la TK, deux systèmes rapporteurs ont été développés, à l'aide de plaques de criblage électrochimique (PCE) constituées de 96 électrodes indépendantes. Le premier système rapporteur repose sur un système bienzymatique nécessitant l'intervention d'une enzyme auxiliaire, la galactose oxydase (GAOx) sous forme libre ou immobilisée dans la laponite. Cette enzyme est capable d'oxyder les produits de réaction de la TK et de produire du peroxyde d'hydrogène. Le format 96 des PCE a permis d'optimiser rapidement la détection électrochimique par ampérométrie pulsée par intermittence (IPA) d'activité oxydase et seulement 10 minutes sont nécessaires pour réaliser 96 mesures simultanées. Parallèlement, afin d'exploiter au maximum le système à 96 électrodes, cette détection d'activité oxydase a également été réalisée, en 10 minutes par électrochimiluminescence. Cette méthode offre l'avantage d'être plus sensible et moins variable que par IPA, mais limite l'utilisation de matrice d'immobilisation d'enzymes. La GAOx a ensuite été utilisée pour mesurer l'activité TK, cependant, les conditions réactionnelles n'étant pas optimales en présence du système bienzymatique (TK-GAOx), des temps d'incubation longs sont nécessaires et sont peu adaptées au criblage d'inhibiteurs de la TK. Un second système rapporteur ne nécessitant plus d'enzyme auxiliaire et faisant intervenir uniquement un seul substrat de la TK a été optimisé. Ce système repose sur l'oxydation de l'intermédiaire réactionnel formé par la fixation du cofacteur (la thiamine pyrophosphate) et du substrat sur l'enzyme par le ferricyanure. Cette méthode permet de mesurer 96 activités TK en seulement 7 minutes et a aisément été utilisée pour cribler une bibliothèque de molécules. Le criblage de 1360 molécules a permis d'identifier un nouvel inhibiteur de cet enzyme, présentant une CI50 de 63 μM. Le système électrochimique a également été utilisé pour déterminer le mécanisme d'inhibition (non compétitive pure partielle) et la constante d'inhibition associée (3,4 μM). Ces résultats sont inédits dans le domaine de l'électrochimie et offrent un large éventail d'applications que ce soit pour le criblage d'activité enzymatiques ou d'inhibiteurs d'enzymes / This thesis focuses on the development of a new electrochemical method allowing the high throughputscreening of enzyme inhibitors. For this purpose, a target enzyme has been selected for its therapeutic interest,transketolase (TK): this enzyme is involved in many diseases (cancer, neurodegenerative diseases, diabetes ...) and inthe survival of pathogenic parasites. To measure TK activity, two reporter systems have been developed by usingelectrochemical plates, composed of 96 independent electrodes.The first one is based on a bienzymatic system, requiring the use of an auxiliary enzyme, galactose oxidase(GAOx), in its soluble form or immobilized in laponite. This enzyme is able to oxidize TK products and producehydrogen peroxide. The 96-well format allowed to quickly optimize the electrochemical detection of oxidase activityby intermittent pulse amperometry (IPA) of oxidase activity and only 10 minutes are required to perform 96simultaneous measurements. In parallel, in order to harness the 96-well electrochemical system, this detection ofoxidase activity was also carried out in 10 minutes using electrochemiluminescence. This method is more sensitiveand less variable than IPA but is limited to the use of soluble enzymes. However, the reaction conditions are notoptimal for the bienzymatic system (TK-GAOx): long incubation times are required and are poorly adapted for thescreening of TK inhibitors.A second reporter system no longer requiring an auxiliary enzyme and involving only one TK substrate hasbeen optimized. This system relies on the oxidation by ferricyanide of the reactional intermediate resulted of thebinding of the cofactor (thiamine pyrophosphate) and the substrate. This method allows to measure 96 TK activitiesin only 7 minutes and was easily used to screen an in-house chemical library. The screening of 1360 molecules leadto the identification of a new TK inhibitor with an IC50 of 63 μM. This electrochemical system was also used todetermine the mechanism of inhibition (partial non-competitive mechanism) and the associated inhibition constant(3.4 μM). These results are innovative in the field of electrochemistry and offer a wide range of applications forenzymatic activity screening or the screening of enzymes inhibitors

<p>The main objective of the reported study was to investigate how biomedical ontologies, logically structured representations of various aspects of the biomedical reality, can help researchers in analyzing experimental data. The dissertation reports two attempts to construct tools for the analysis of high-throughput experimental results using explicit domain knowledge representations. Furthermore, integrative efforts made by the community of Open Biomedical Ontologies (OBO), in which the author has participated, are reported, and a framework for consistently connecting the Gene Ontology (GO) with the Taxonomy of Species is proposed and discussed.</p>

Biological data derived from high-throughput microarrays can be transformed into finite, simple, undirected graphs and analyzed using tools first introduced by the Langston Lab at the University of Tennessee. Transforming raw data can be broken down into three main tasks: data normalization, generation of similarity metrics, and threshold selection. The choice of methods used in each of these steps effect the final outcome of the graph, with respect to size, density, and structure. A number of different algorithms are examined and analyzed to illustrate the magnitude of the effects. Graph-based tools are then used to extract putative gene networks. These tools are loosely based on the concept of clique, which generates clusters optimized for density. Innovative additions to the paraclique algorithm, developed at the Langston Lab, are introduced to generate results that have highest average correlation or highest density. A new suite of algorithms is then presented that exploits the use of a priori gene interactions. Aptly named the anchored analysis toolkit, these algorithms use known interactions as anchor points for generating subgraphs, which are then analyzed for their graph structure. This results in clusters that might have otherwise been lost in noise. A main product of this thesis is a novel collection of algorithms to generate exact solutions to the maximum clique problem for graphs that are too large to fit within core memory. No other algorithms are currently known that produce exact solutions to this problem for extremely large graphs. A combination of in-core and out-of-core techniques is used in conjunction with a distributed-memory programming model. These algorithms take into consideration such pitfalls as external disk I/O and hardware failure and recovery. Finally, a web-based tool is described that provides researchers access the aforementioned algorithms. The Graph Algorithms Pipeline for Pathway Analysis tool, GrAPPA, was previously developed by the Langston Lab and provides the software needed to take raw microarray data as input and preprocess, analyze, and post-process it in a single package. GrAPPA also provides access to high-performance computing resources, via the TeraGrid.

The concept of the gene has been constantly challenged by new discoveries in the life sciences. Recent challenging observations include the high frequency of alternative splicing events and the common transcription of non-protein-coding-RNAs (ncRNAs) from the genome. The latter has long been considered noise in biological systems. Multiple lines of evidence from genomic studies indicate that alternative splicing and ncRNA play important roles in expanding proteome diversity in eukaryotes. Here, the aim is to find the link between alternative splicing and ncRNAs by studying the expression profile of the spliceosomal snRNAs (U snRNA). Spliceosomal snRNAs are essential for pre-mRNA splicing in eukaryotes. They participate in splice site selection, recruitment of protein factors and catalyzing the splicing reaction. Because of this, both the abundance and diversity of U snRNAs were expected to be large. In our study we deeply analyzed the U snRNA population in primates using a combination of bioinformatical, biochemical and high throughput sequencing approaches. This transcriptome profiling has revealed that human, chimpanzee and rhesus have similar U snRNA populations, i.e. the vast majority of U snRNAs originate from few well-defined gene loci and the heterogeneity observed in U snRNA populations was largely due to the presence of SNPs at these loci. It seems that the gene loci that could potentially encode a significantly heterogeneous population of U snRNAs are mostly silent. Only few minority transcripts were detected in our study, and among them three U1-like snRNAs might play a role in the regulation of alternative splicing by recognizing non-canonical splicing sites. Mutations of U snRNA have been shown to impact the splicing process. Therefore, our study provides a reference to study the biological significance of SNPs in U snRNA genes and their association with diseases.

The main objective of the reported study was to investigate how biomedical ontologies, logically structured representations of various aspects of the biomedical reality, can help researchers in analyzing experimental data. The dissertation reports two attempts to construct tools for the analysis of high-throughput experimental results using explicit domain knowledge representations. Furthermore, integrative efforts made by the community of Open Biomedical Ontologies (OBO), in which the author has participated, are reported, and a framework for consistently connecting the Gene Ontology (GO) with the Taxonomy of Species is proposed and discussed.

Throughout this thesis work, various catalysts were investigated with combinational approach to develop highly active and selective novel catalysts for direct epoxidation of propylene to PO using molecular oxygen. The promoted and un-promoted silver (Ag), copper (Cu), ruthenium (Ru), manganese (Mn) mono and multimetallic catalytic systems over different silica supports were prepared via sol-gel method and incipient wetness method. In addition to support effect, the effects of different promoters on the catalytic performances of these catalyst candidates were investigated. The study showed that commercial silica (c-SiO2) is the most effective support when compared to silica (SiO2) and silica synthesized with templete (t-SiO2). Among bimetallic catalytic systems containing Ag, Ru, Mn and Cu metals, c-SiO2 supported Cu-Ru catalyst was determined as the most active catalytic system. In addition, the most effective v catalyst and promoter in the epoxidation reaction was determined as NaCI promoted Cu-Ru catalyst supported over c-SiO2 with 35.98% selectivity&amp / 9.55% conversion (3.44% yield) at 3000C and 0.5 feed gas ratio (C3H6/O2).. In the study, the selected catalysts showed low and high PO productivity were also investigated by characterization techniques such as XRD, XPS, BET and FTIR.It was inferred from characterization tests that bimetallic systems reveal a synergistic behavior by exposing more active sites on the silica support material with respect to their monometallic counterparts. Besides, NaCl catalytic promoter has a strong interaction particularly with the Cu sites on the Cu/Ru/SiO2 catalyst surface, altering the electronic structure of Cu sites that favors to PO production.

Preclinical methods for the identification and characterization of molecules for development into new cancer drugs were investigated. Based on repurposing, i.e. the exploration of currently prescribed drugs for new indications, and as a result of a new high throughput screening (HTS) approach, the benzimidazoles benomyl and carbendazim, the alkaloid cryptolepine and the acridine acriflavine were found interesting to characterize using these methods. In mice the benzimidazoles inhibited 3H-thymidine incorporation in tissues with high cell renewal, with benomyl being more active than carbendazim.  They were rapidly absorbed with highest amounts seen in the liver, kidneys and gastro-intestinal lumen as evidenced from distribution of 14C-labeled drugs. In human tumour cell lines, the benzimidazoles showed a similar activity pattern but benomyl was more potent. This was true also in tumour cells from patients but carbendazim was relatively more active against solid tumours. Analyses of drug activity cross-resistance patterns and of drug activity – gene expression correlations in a cell line panel suggested multiple mechanisms of action for the benzimidazoles. Cryptolepine was widely distributed to tissues in vivo in the mice. It was more potent than the benzimidazoles in tumour cells, with highest activity in haematological malignancies but some patient samples of breast, colon and non small-cell lung cancer were sensitive. Cross-resistance analysis indicated cryptolepine to be a topoisomerase II inhibitor whereas drug activity – gene expression correlations suggested additional mechanisms of action. HTS on 2 000 molecules in colon cancer cell lines and normal cells identified acriflavine as a hit molecule, subsequently shown to have unprecedented activity against colorectal cancer tumour cells in patient tumour samples. Connectivity map analysis, based on drug induced gene expression perturbation patterns in a tumour cell line, indicated acriflavine to be a topoisomerase inhibitor, subsequently confirmed in a plasmid relaxation assay. In conclusion, repurposing of drugs and HTS using stringent activity criteria followed by preclinical characterization might contribute to more efficient development of new cancer drugs.

To understand the cellular processes, knowledge of the localization and function of proteins are essential. There are several high throughput ventures examining the human proteome. However, there are some bottlenecks in these ventures. For example the production and expression of soluble proteins for analysis. Another obstacle for affinity proteomics is the generation of high quality antibodies, invaluable tools in biotechnological applications. The objective in this thesis was to facilitate protein purification and sample preparation before analysis and downstream applications. We also aimed to attain more information on what constitutes an ideal immunogen, and on how different immune systems respond to a common amino acid sequence.   In one of the projects an automated purification set-up was developed to ensure high recovery of up to milligram amounts of protein with high purity. The system allowed up to 60 recombinant proteins to be purified under both native and denaturing conditions. In another project, the same developed set-up was additionally shown to work with an alternative chromatography resin with small adjustments. Instead of immobilized metal ion affinity chromatography, used in the first project, ion exchange chromatography was applied under denaturing conditions, with good results. To further automate the production line in high throughput projects, an automated sample preparation was set up for mass spectrometry and e.g. gel electrophoresis analysis. We showed that a crude cell lysate could be used as input in the magnetic bead based system, and totally absent from manual handling, the output was purified and buffer exchanged samples ready for mass spectrometry analysis, as well as a fraction of sample that could be used for complementary analyses, for example gel electrophoresis to determine the protein concentration and purity.   The other objective was – as noted – to gain better comprehension of antibody generation to foreign proteins, and to shed more light over how to design a good antigen. First was a solubility assay developed that determined the remaining fraction of soluble protein after reduction of the concentration of denaturing agent. The assay was performed in a 96 deep well plate, and only instrumentation available in a standard laboratory was necessary. The fact that the assay could be automated on a pipetting robot, increased the throughput and reduced the necessary manual handling. Obtained information on antigen solubility was correlated to the cognate antibody titers. At average the antibody yield was higher when a soluble antigen was used for immunization. Also, the probability of failing in eliciting an immune response was increased if an insoluble antigen was used. However, the antibody titers in each solubility class were highly diverse, and thus also some insoluble antigens were found that provoked the immune system. To further examine the differences between different B cell repertoires, a massive epitope mapping was performed with more than 400 different antisera reacting to the same amino acid sequence. Antigenic hot spot regions were discovered, as well as regions depleted in antibody recognition. However, in one third of the antisera the most abundant antigenic region did not elicit any binding of antibodies. This further validates the conclusion that good antigen design is essential, however is it not certain the outcome of immunizations can ever be determined a priori due to the variability between hosts. An alternative to immunization is selection of affinity reagents by phage display. In the last project an initial parallelized set-up selected antibody fragments that showed high specificity and were compatible with several biotechnological applications, making the set-up a promising alternative to conventional immunization in proteome-wide endeavors. / QC 20101102